Richard R. DeLuca Jr.
Executive Vice President and President, Merck Animal Health, Merck
In the news
Merck executives DeLuca and Guindo sell 21,050 shares at about $130-131 on August 6
SEC Form 4 filings show two Merck executives sold stock on August 6, 2026, days after the second-quarter report.
Insiders